Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety, Tolerability, and Clinical Pharmacology of Subcutaneous Rjv001 in Adult Subjects Undergoing Abdominoplasty

NCT04821648 is registered in ClinicalTrials.gov with Rejuven Dermaceutical Co., Ltd. as lead sponsor.

NCT NCT04821648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety, Tolerability, and Clinical Pharmacology of Subcutaneous Rjv001 in Adult Subjects Undergoing Abdominoplasty
Lead sponsor
Rejuven Dermaceutical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
April 16, 2021
Completion date
December 16, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

double chin, submental fat (smf)